At 24 weeks, the average reduction was 17.5%, and lead investigator Ania Jastreboff of Yale School of Medicine told the ADA that trial participants had not reached a plateau in their weight by the ...
Food and Drug Administration. Drug trials snapshots: Mounjaro. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216.
Have you been trying to lose weight but feel like you’re trying to climb an insurmountable mountain? As you grow older, gaining weight becomes the easiest thing you can do. When left unchecked ...